taxonomy (7)
protein (61)
source (16)
structure (20)
composition (1)
disease (7)
reference (22)
site (78)
peptide (70)
- Homo sapiens (Human)
- Bos taurus (Bovine)
- Ovis aries (Sheep)
- Rattus norvegicus (Norway rat)
- Sus scrofa (Pig)
- Calloselasma rhodostoma (Malayan pit viper)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- Alpha-2-HS-glycoprotein / Homo sapiens P02765
- Asporin / Homo sapiens Q9BXN1
- Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe / Homo sapiens Q8NES3
- Biglycan / Homo sapiens P21810
- Calponin-3 / Homo sapiens Q15417
- Calsyntenin-2 / Homo sapiens Q9H4D0
- CD59 glycoprotein / Homo sapiens P13987
- Ceruloplasmin / Homo sapiens P00450
- Clusterin / Homo sapiens P10909
- Collagen alpha-1(XII) chain / Homo sapiens Q99715
- Collagen alpha-1(XIV) chain / Homo sapiens Q05707
- Decorin / Homo sapiens P07585
- Fibromodulin / Homo sapiens Q06828
- Fibulin-5 / Homo sapiens Q9UBX5
- GDNF family receptor alpha-1 / Homo sapiens P56159
- Glucosylceramidase / Homo sapiens P04062
- Glycodelin-a / Homo sapiens P09466
- Glycoprotein hormones alpha chain - choriogonadotropin / Homo sapiens P01215
- Golgi apparatus protein 1 / Homo sapiens Q92896
- Golgi membrane protein 1 / Homo sapiens Q8NBJ4
- Inactive tyrosine-protein kinase 7 / Homo sapiens Q13308
- Inositol monophosphatase 3 / Homo sapiens Q9NX62
- Kininogen-1 / Homo sapiens P01042
- Lactotransferrin / Homo sapiens P02788
- Lumican / Homo sapiens P51884
- Lutropin beta chain / Homo sapiens P01229
- Mammaglobin-A / Homo sapiens Q13296
- Metalloproteinase inhibitor 1 / Homo sapiens P01033
- Olfactomedin-4 / Homo sapiens Q6UX06
- Olfactomedin-like protein 3 / Homo sapiens Q9NRN5
- Periostin / Homo sapiens Q15063
- Polymeric immunoglobulin receptor / Homo sapiens P01833
- Prolactin-inducible protein / Homo sapiens P12273
- Prolargin / Homo sapiens P51888
- Prominin-1 / Homo sapiens O43490
- Prosaposin / Homo sapiens P07602
- Prostaglandin F2 receptor negative regulator / Homo sapiens Q9P2B2
- Prostaglandin-h2 d-isomerase / Homo sapiens P41222
- Prostate-specific antigen (psa-1) / Homo sapiens P07288
- Prostate-specific antigen - high Pi isoform (psah) / Homo sapiens P07288
- Protein YIPF3 / Homo sapiens Q9GZM5
- Stanniocalcin-2 / Homo sapiens O76061
- Thrombospondin-1 / Homo sapiens P07996
- Tissue-type plasminogen activator / Homo sapiens P00750
- Translocon-associated protein subunit alpha / Homo sapiens P43307
- Uromodulin / Homo sapiens P07911
- Vitamin k-dependent protein c / Homo sapiens P04070
- WAP four-disulfide core domain protein 2 / Homo sapiens Q14508
- Zinc-alpha-2-glycoprotein / Homo sapiens P25311
- Acetylcholinesterase / Bos taurus P23795
- Major prion protein (VRQ/VRQ polymorphism) 21K slow variant / Ovis aries Q712V9
- Major prion protein (VRQ/VRQ polymorphism) CH1641 variant / Ovis aries Q712V9
- Neuroligin 1 / Rattus norvegicus Q62765
- 32 kDa enamelin / Sus scrofa O97939
- Major seminal plasma glycoprotein psp-i / Sus scrofa P35495
- Major seminal plasma glycoprotein psp-ii / Sus scrofa P35496
- Mucin / Sus scrofa
- Ancrod / Calloselasma rhodostoma P26324
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Amniotic Fluid (UBERON_0000173)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Enamel Organ (UBERON_0005176)
- Kidney (UBERON_0002113) HEK293-EBNA (CVCL_6974)
- Kidney (UBERON_0002113)
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Pituitary Gland (UBERON_0000007)
- Seminal Fluid (UBERON_0006530)
- Skin of Body (UBERON_0002097) HMCB (CVCL_3317)
- Trachea (UBERON_0003126)
- Urine (UBERON_0001088)
- Venom (UBERON_0007113)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
Source
- N-Linked / Complex / NeuAc(?2-?)Hex(?1-?)HexNAc(?1-?)Man(a1-?)[NeuAc(?2-?)HexNAc(?1-?)HexNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-3)[NeuAc(a2-6)]GlcNAc(b1-4)[GlcNAc(b1-2)]Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-3)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-3)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(?1-?)GlcNAc(b1-2)Man(a1-?)[NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-?)[NeuAc(a2-?)GalNAc(?1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
- N-Linked / Complex / Structure 9386
- N-Linked / Complex / Structure 9599
- N-Linked / Complex / Structure 9823
- N-Linked / Complex / Structure 9946
- N-Linked / Complex / Structure 10051
- N-Linked / Complex / Structure 10106
- N-Linked / Complex / Structure 10710
- N-Linked / Complex / Structure 10810
- N-Linked / Complex / Structure 10982
- N-Linked / Undefined core / NeuAc(??-?)HexNAc(??-?)HexNAc(??-?)Hex(??-?)[NeuAc(??-?)Hex(??-?)HexNAc(??-?)Hex(??-?)]Hex(??-?)HexNAc(??-?)[Fuc(??-?)]HexNAc
- O-Linked / Core 2 / NeuAc(a2-3)Gal(b1-3)GlcNAc(b1-3)[GlcNAc(b1-6)]Gal(b1-4)GlcNAc(b1-3)[NeuAc(a2-6)]Gal(b1-3)[Fuc(a1-2)Gal(b1-4)GlcNAc(b1-6)]GalNAc
- O-Linked / Core 2 / Structure 9479
Reported structure
- Cancer, breast (DOID:1612)
- COVID-19 (DOID:0080600)
- Melanoma (DOID:1909)
- Oral squamous cell carcinoma (DOID:0050866)
- Prostate cancer (DOID:10283)
- Prostate Disease (DOID:47)
- Scrapie (DOID:5434)
Disease
- Profiling the proteoforms of urinary prostate-specific antigen by capillary electrophoresis – mass spectrometry (2021 - Alan B. Moran, Elena Domínguez-Vega, Jan Nouta, Tamas Pongracz, Theo M. de Reijke, Manfred Wuhrer, Guinevere S.M. Lageveen-Kammeijer) / Status : Reviewed
- High-throughput glycopeptide profiling of prostate-specific antigen from seminal plasma by MALDI-MS. (2021 - Wei Wang, Anna Kałuża, Jan Nouta, Simone Nicolardi, Mirosława Ferens-Sieczkowska, Manfred Wuhrer, Guinevere S M Lageveen-Kammeijer, Noortje de Haan) / Status : Reviewed
- Site-specific analysis of N-glycans from different sheep prion strains (2021 - Natali Nakić ,Thanh Hoa Tran ,Mislav Novokmet,Olivier Andreoletti,Gordan Lauc,Giuseppe Legname) / Status : Reviewed
- Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells (2021 - Christoph Gstöttner, Tao Zhang, Anja Resemann, Sophia Ruben, Stuart Pengelley, Detlev Suckau, Tim Welsink, Manfred Wuhrer, Elena Domínguez-Vega) / Status : Reviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Novel O-linked sialoglycan structures in human urinary glycoproteins (2020 - Adam Pap, Ervin Tasnadi, Katalin F. Medzihradszky, Zsuzsanna Darula ) / Status : Reviewed
- Quantitative Longitudinal Inventory of the N-Glycoproteome of Human Milk from a Single Donor Reveals the Highly Variable Repertoire and Dynamic Site-Specific Changes (2020 - Jing Zhu, Yu-Hsien Lin, Kelly A Dingess, Marko Mank, Bernd Stahl, Albert J R Heck) / Status : Reviewed
- Tongue Cancer Patients Can be Distinguished from Healthy Controls by Specific N-Glycopeptides Found in Serum. (2018 - Mayank Saraswat, Antti Mäkitie, Tiialotta Tohmola, Amy Dickinson, Shruti Saraswat, Sakari Joenväärä, Suvi Renkonen) / Status : Reviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Glycoproteomics: Identifying the Glycosylation of Prostate Specific Antigen at Normal and High Isoelectric Points by LC-MS/MS (2014 - Song E, Mayampurath A, Yu CY, Tang H, Mechref Y) / Status : Reviewed
- Structural characterization of recombinant soluble rat neuroligin 1: mapping of secondary structure and glycosylation by mass spectrometry. (2004 - Hoffman RC, Jennings LL, Tsigelny I, Comoletti D, Flynn RE, Sudhof TC, Taylor P) / Status : Reviewed
- Hierarchy of post-translational modifications involved in the circulatory longevity of glycoproteins. Demonstration of concerted contributions of glycan sialylation and subunit assembly to the pharmacokinetic behavior of bovine acetylcholinesterase. (2000 - Kronman C, Chitlaru T, Elhanany E, Velan B, Shafferman A) / Status : Reviewed
- Structural characterization of the oligosaccharide chains of native and crystallized boar seminal plasma spermadhesin PSP-I and PSP-II glycoforms. (1999 - Nimtz M, Grabenhorst E, Conradt H, Sanz L, Calvete J) / Status : Reviewed
- Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities. (1995 - Dell A, Morris H, Easton R, Panico M, Patankar M, Oehniger S, Koistinen R, Koistinen H, Seppala M, Clark G) / Status : Reviewed
- Carbohydrate moieties of porcine 32 kDa enamelin. (1995 - Yamakoshi Y) / Status : Reviewed
- Novel Asn-linked oligosaccharides terminating in GalNAc beta (1-->4)[Fuc alpha (1-->3)]GlcNAc beta (1-->.) are present in recombinant human protein C expressed in human kidney 293 cells. (1993 - Yan S, Chao Y, van Halbeek H) / Status : Reviewed
- Carbohydrate structure of a thrombin-like serine protease from Agkistrodon rhodostoma. Structure elucidation of oligosaccharides by methylation analysis, liquid secondary-ion mass spectrometry and proton magnetic resonance. (1992 - Pfeiffer G, Dabrowski U, Dabrowski J, Stirm S, Strube K, Geyer R) / Status : Reviewed
- A novel sialylated N-acetylgalactosamine-containing oligosaccharide is the major complex-type structure present in Bowes melanoma tissue plasminogen activator. (1991 - Chan A, Morris H, Panico M, Etienne A, Rogers M, Gaffney P, Creighton-Kempsford L, Dell A) / Status : Reviewed
- NMR investigations of the N-linked oligosaccharides at individual glycosylation sites of human lutropin. (1991 - Weisshaar G, Hiyama J, Renwick A, Nimtz M) / Status : Reviewed
- Structures of the sialylated oligosaccharide chains in swine tracheal mucin glycoproteins. (1987 - Rana SS, Chandrasekaran EV, Mendicino J) / Status : Reviewed
Reference
- Alpha-2-HS-glycoprotein / Homo sapiens
- Asporin / Homo sapiens
- Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe / Homo sapiens
- Biglycan / Homo sapiens
- Calponin-3 / Homo sapiens
- Calsyntenin-2 / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Clusterin / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-1(XIV) chain / Homo sapiens
- Decorin / Homo sapiens
- Fibromodulin / Homo sapiens
- Fibulin-5 / Homo sapiens
- GDNF family receptor alpha-1 / Homo sapiens
- Glucosylceramidase / Homo sapiens
- Glycodelin-a / Homo sapiens
- Glycoprotein hormones alpha chain - choriogonadotropin / Homo sapiens
- Golgi apparatus protein 1 / Homo sapiens
- Golgi membrane protein 1 / Homo sapiens
- Inactive tyrosine-protein kinase 7 / Homo sapiens
- Inositol monophosphatase 3 / Homo sapiens
- Kininogen-1 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Lumican / Homo sapiens
- Lutropin beta chain / Homo sapiens
- Mammaglobin-A / Homo sapiens
- Metalloproteinase inhibitor 1 / Homo sapiens
- Olfactomedin-4 / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Periostin / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prolargin / Homo sapiens
- Prominin-1 / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Prostate-specific antigen (psa-1) / Homo sapiens
- Prostate-specific antigen - high Pi isoform (psah) / Homo sapiens
- Protein YIPF3 / Homo sapiens
- Stanniocalcin-2 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Tissue-type plasminogen activator / Homo sapiens
- Translocon-associated protein subunit alpha / Homo sapiens
- Uromodulin / Homo sapiens
-
Vitamin k-dependent protein c / Homo sapiens
- Undefined site
- WAP four-disulfide core domain protein 2 / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
-
Acetylcholinesterase / Bos taurus
- Undefined site
- Major prion protein (VRQ/VRQ polymorphism) 21K slow variant / Ovis aries
- Major prion protein (VRQ/VRQ polymorphism) CH1641 variant / Ovis aries
-
Neuroligin 1 / Rattus norvegicus
- Undefined site
-
32 kDa enamelin / Sus scrofa
- Undefined site
- Major seminal plasma glycoprotein psp-i / Sus scrofa
- Major seminal plasma glycoprotein psp-ii / Sus scrofa
-
Mucin / Sus scrofa
- Undefined site
-
Ancrod / Calloselasma rhodostoma
- Undefined site
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- TAVNCSSDFDACLITK (16aa)
- TGVCPELQADQNCTQECVSDSECADNLK (28aa)
- WFSAGLASNSSWLR (14aa)
- ELLQEFIDDNATTNAIDELK (20aa)
- FVGTPEVNQTTIYQR (15aa)
- ETNFSIASGIEAK (13aa)
- AVCGGVLVHPQWVLTAAHCIRNK (23aa)
- AVCGGVLVHPQWVLTAAHCIRNKSVILLGR (30aa)
- NKSVLLGR (8aa)
- NK (2aa)
- LSLQNTAEIQHCLVNAGDVGCGVFECFENNSCEIR (35aa)
- SVVAPATDGGLNLTSTFLRK (20aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- KEDALNETR (9aa)
- AFENVTDLQWLILDHNLLENSK (22aa)
- AIIQGLMPDQNYTVQIIAYNK (21aa)
- IHGQELPFEAVVLNK (15aa)
- TCDWIPKPNMSASCK (15aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- TFYWDFYTNR (10aa)
- DIVEYYNDSNGSHVIQGR (18aa)
- AVIVNNITTGER (12aa)
- SANASFNIK (9aa)
- TQSLLIVNNATNVVIK (16aa)
- KLHINHNNLTESVGPLPK (18aa)
- LHINHNNLTESVGPLPK (17aa)
- FYIQNFTALPLNTVVPPQR (19aa)
- EHEGAIYPDNTTDFQR (16aa)
- TAGWNVPIGTIRPFINWTGPPEPIEAAVAR (30aa)
- IYIDHNNITR (10aa)
- HTGNVVITNCSAAHSR (16aa)
- AALAAFNAQNNGSNFQLEEISR (22aa)
- IYVIDGTQNDTAFVFPR (17aa)
- YPNQVYYRPVDQYSNQNNFVHDCVNITVK (29aa)
- GNITEYQCHQYITK (14aa)
- TNSTFVQALVEHVK (14aa)
- CNTAAPMWLNGTHPSSDEGIVSR (23aa)
- ITIQPVDNSTISIQMGTNK (19aa)
- GCSSSTSVLLTLDNNVVNGSSPAIR (25aa)
- QVAIQTFGNQTTIIPAGGAGYK (22aa)
- GLSFNSISAVDNGSLANTPHLR (22aa)
- IGISFNSISAVDNGSIANTPHIR (23aa)
- MIENGSISFIPTIR (14aa)
- EALENMNSTLK (11aa)
- ITDIENGSIANIPR (14aa)
- NVSVAEGK (8aa)
- LNAENNATFYFK (12aa)
- SCQDINECEHRNHTCNLQQTCYNLQGGFK (29aa)
- YIQVVYLHNNNISVVGSSDFCPPGHNTK (28aa)
- DIGPTIANSTHHNVR (15aa)
- IIQVVYIHSNNITK (14aa)
- LQVVYLHSNNITK (13aa)
- QDFNITDISLLEHR (14aa)
- INGTQICPNDIVAFHDFSSDIENVPHIR (28aa)
- FPNIT (5aa)
- RFPNIT (6aa)
- IIDNNKTEK (9aa)
- AVAVTLQSH (9aa)
- MINTSSIIEQINEQFNWVSR (20aa)
- AGIQAFFQVQECNK (14aa)
- VSCPIMPCSNATVPDGECCPR (21aa)
- IANITQGEDQYYIR (14aa)
- LNDTTLQVLNTWYTK (15aa)
- LSLLEEPGNGTFTVILNQLTSR (22aa)
- VPGNVTAVLGETLK (14aa)
- TAGWNIPMGIIFNQTGSCK (19aa)
- RTAGWNIPMGLLFNQTGSCKF (21aa)
- KWNNTGCQALPSQDEGPSKA (20aa)
- EVNDTLLVNELK (12aa)
- EAGNITTDGYEIIGK (15aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 2411.2187)
-
Neuroligin 1 / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Enamel Organ (UBERON_0005176)
- Carbohydrate moieties of porcine 32 kDa enamelin. (1995 - Yamakoshi Y) / Status : Reviewed
-
32 kDa enamelin / Sus scrofa
- Undefined site
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Venom (UBERON_0007113)
-
Ancrod / Calloselasma rhodostoma
- Undefined site
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Novel Asn-linked oligosaccharides terminating in GalNAc beta (1-->4)[Fuc alpha (1-->3)]GlcNAc beta (1-->.) are present in recombinant human protein C expressed in human kidney 293 cells. (1993 - Yan S, Chao Y, van Halbeek H) / Status : Reviewed
- NMR investigations of the N-linked oligosaccharides at individual glycosylation sites of human lutropin. (1991 - Weisshaar G, Hiyama J, Renwick A, Nimtz M) / Status : Reviewed
- Glycoprotein hormones alpha chain - choriogonadotropin / Homo sapiens
- Lutropin beta chain / Homo sapiens
-
Vitamin k-dependent protein c / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Melanoma (DOID:1909)
- Tissue-type plasminogen activator / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Seminal Fluid (UBERON_0006530)
- Major seminal plasma glycoprotein psp-i / Sus scrofa
- Major seminal plasma glycoprotein psp-ii / Sus scrofa
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Amniotic Fluid (UBERON_0000173)
- Glycodelin-a / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Kidney (UBERON_0002113)
-
Acetylcholinesterase / Bos taurus
- Undefined site
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Milk (UBERON_0001913)
- Lactotransferrin / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- RTAGWNIPMGLLFNQTGSCKF (21aa)
- KWNNTGCQALPSQDEGPSKA (20aa)
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Seminal Fluid (UBERON_0006530)
- Prostate-specific antigen (psa-1) / Homo sapiens
- NK (2aa)
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Seminal Fluid (UBERON_0006530)
- Prostate-specific antigen (psa-1) / Homo sapiens
- NK (2aa)
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Brain (UBERON_0000955)
- Scrapie (DOID:5434)
- Major prion protein (VRQ/VRQ polymorphism) 21K slow variant / Ovis aries
- Major prion protein (VRQ/VRQ polymorphism) CH1641 variant / Ovis aries
- YPNQVYYRPVDQYSNQNNFVHDCVNITVK (29aa)
-
- N-Linked / Complex
(avg mass : 2411.2187)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
-
- N-Linked / Complex
(avg mass : 2411.2187)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FPNIT (5aa)
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Urine (UBERON_0001088)
- Prostate-specific antigen (psa-1) / Homo sapiens
- NK (2aa)
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Urine (UBERON_0001088)
- Prostate-specific antigen (psa-1) / Homo sapiens
- NK (2aa)
-
- N-Linked / Complex
(avg mass : 2411.2187)
- Seminal Fluid (UBERON_0006530)
- Prostate-specific antigen (psa-1) / Homo sapiens
- Prostate-specific antigen - high Pi isoform (psah) / Homo sapiens
- AVCGGVLVHPQWVLTAAHCIRNK (23aa)
- AVCGGVLVHPQWVLTAAHCIRNKSVILLGR (30aa)
- NKSVLLGR (8aa)
-
- N-Linked / Undefined core
(avg mass : 2411.2187)
- Blood Serum (UBERON_0001977)
- Alpha-2-HS-glycoprotein / Homo sapiens
- AALAAFNAQNNGSNFQLEEISR (22aa)
-
- O-Linked / Core 2
(avg mass : 2411.2187)
- Trachea (UBERON_0003126)
-
Mucin / Sus scrofa
- Undefined site
-
- O-Linked / Core 2
(avg mass : 2411.2187)
- Urine (UBERON_0001088)
- Protein YIPF3 / Homo sapiens
- AVAVTLQSH (9aa)
-
- Hex:4 HexNAc:5 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2411.2187)
- N-Linked / Complex / NeuAc(?2-?)Hex(?1-?)HexNAc(?1-?)Man(a1-?)[NeuAc(?2-?)HexNAc(?1-?)HexNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-3)[NeuAc(a2-6)]GlcNAc(b1-4)[GlcNAc(b1-2)]Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-3)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-3)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(?1-?)GlcNAc(b1-2)Man(a1-?)[NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(?1-?)Man(a1-?)[NeuAc(a2-?)GalNAc(?1-?)GlcNAc(?1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-?)]GlcNAc
- N-Linked / Complex / Structure 9386
- N-Linked / Complex / Structure 9599
- N-Linked / Complex / Structure 9823
- N-Linked / Complex / Structure 9946
- N-Linked / Complex / Structure 10051
- N-Linked / Complex / Structure 10106
- N-Linked / Complex / Structure 10710
- N-Linked / Complex / Structure 10810
- N-Linked / Complex / Structure 10982
- N-Linked / Undefined core / NeuAc(??-?)HexNAc(??-?)HexNAc(??-?)Hex(??-?)[NeuAc(??-?)Hex(??-?)HexNAc(??-?)Hex(??-?)]Hex(??-?)HexNAc(??-?)[Fuc(??-?)]HexNAc
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Asporin / Homo sapiens
- Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe / Homo sapiens
- Biglycan / Homo sapiens
- Calponin-3 / Homo sapiens
- Calsyntenin-2 / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Clusterin / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-1(XIV) chain / Homo sapiens
- Decorin / Homo sapiens
- Fibromodulin / Homo sapiens
- Fibulin-5 / Homo sapiens
- GDNF family receptor alpha-1 / Homo sapiens
- Glucosylceramidase / Homo sapiens
- Golgi apparatus protein 1 / Homo sapiens
- Golgi membrane protein 1 / Homo sapiens
- Inactive tyrosine-protein kinase 7 / Homo sapiens
- Inositol monophosphatase 3 / Homo sapiens
- Kininogen-1 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Lumican / Homo sapiens
- Mammaglobin-A / Homo sapiens
- Metalloproteinase inhibitor 1 / Homo sapiens
- Olfactomedin-4 / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Periostin / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prolargin / Homo sapiens
- Prominin-1 / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Stanniocalcin-2 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Translocon-associated protein subunit alpha / Homo sapiens
- Uromodulin / Homo sapiens
- WAP four-disulfide core domain protein 2 / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TAVNCSSDFDACLITK (16aa)
- TGVCPELQADQNCTQECVSDSECADNLK (28aa)
- WFSAGLASNSSWLR (14aa)
- ELLQEFIDDNATTNAIDELK (20aa)
- FVGTPEVNQTTIYQR (15aa)
- ETNFSIASGIEAK (13aa)
- LSLQNTAEIQHCLVNAGDVGCGVFECFENNSCEIR (35aa)
- SVVAPATDGGLNLTSTFLRK (20aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- KEDALNETR (9aa)
- AFENVTDLQWLILDHNLLENSK (22aa)
- AIIQGLMPDQNYTVQIIAYNK (21aa)
- IHGQELPFEAVVLNK (15aa)
- TCDWIPKPNMSASCK (15aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- TFYWDFYTNR (10aa)
- DIVEYYNDSNGSHVIQGR (18aa)
- AVIVNNITTGER (12aa)
- SANASFNIK (9aa)
- KLHINHNNLTESVGPLPK (18aa)
- LHINHNNLTESVGPLPK (17aa)
- FYIQNFTALPLNTVVPPQR (19aa)
- EHEGAIYPDNTTDFQR (16aa)
- TAGWNVPIGTIRPFINWTGPPEPIEAAVAR (30aa)
- IYIDHNNITR (10aa)
- HTGNVVITNCSAAHSR (16aa)
- IYVIDGTQNDTAFVFPR (17aa)
- GNITEYQCHQYITK (14aa)
- TNSTFVQALVEHVK (14aa)
- CNTAAPMWLNGTHPSSDEGIVSR (23aa)
- ITIQPVDNSTISIQMGTNK (19aa)
- GCSSSTSVLLTLDNNVVNGSSPAIR (25aa)
- QVAIQTFGNQTTIIPAGGAGYK (22aa)
- GLSFNSISAVDNGSLANTPHLR (22aa)
- IGISFNSISAVDNGSIANTPHIR (23aa)
- MIENGSISFIPTIR (14aa)
- EALENMNSTLK (11aa)
- ITDIENGSIANIPR (14aa)
- NVSVAEGK (8aa)
- LNAENNATFYFK (12aa)
- SCQDINECEHRNHTCNLQQTCYNLQGGFK (29aa)
- YIQVVYLHNNNISVVGSSDFCPPGHNTK (28aa)
- DIGPTIANSTHHNVR (15aa)
- IIQVVYIHSNNITK (14aa)
- LQVVYLHSNNITK (13aa)
- QDFNITDISLLEHR (14aa)
- INGTQICPNDIVAFHDFSSDIENVPHIR (28aa)
- RFPNIT (6aa)
- IIDNNKTEK (9aa)
- MINTSSIIEQINEQFNWVSR (20aa)
- AGIQAFFQVQECNK (14aa)
- VSCPIMPCSNATVPDGECCPR (21aa)
- IANITQGEDQYYIR (14aa)
- LNDTTLQVLNTWYTK (15aa)
- LSLLEEPGNGTFTVILNQLTSR (22aa)
- VPGNVTAVLGETLK (14aa)
- TAGWNIPMGIIFNQTGSCK (19aa)
- EVNDTLLVNELK (12aa)
- EAGNITTDGYEIIGK (15aa)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:5 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2411.2187)
Source
Reported glycosite
Mass spectrometry observed peptide
- O-Linked / Core 2
(avg mass : 2411.2187)
Source
Reported glycosite
- O-Linked / Core 2
(avg mass : 2411.2187)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Undefined core
(avg mass : 2411.2187)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)
Source
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)
Reported glycosite
- N-Linked / Complex
(avg mass : 2411.2187)